Transgenic approaches for modifying the mammary gland to produce therapeutic proteins

Donato Romagnolo, R. P. DiAugustine

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bioengineering of the mammary gland to produce proteins of therapeutic and industrial value is the result of extensive investigation of thy physiology of the mammary gland and the ability to generate transgenic animals. Targeting the expression of heterologous proteins to mammary tissue requires a thorough understanding of the biochemical events that coordinate growth and differentiation of the mammary gland and of the hormonal and developmental regulation of expression of milk protein genes. The characterization of mammary-specific promoter regions in milk protein genes and knowledge of the mechanisms that confer integration site-independent expression of transgenes have significantly contributed to modifying the mammary gland to produce heterologous proteins of therapeutic interest. The generation of large transgenic farm animals provides the opportunity for large-scale production of proteins in milk that have a therapeutic value are naturally present at low concentrations in biological fluids. Transgenic mammary epithelial cells offer a versatile research model in biomedical, environmental health, and neonatal toxicology research.

Original languageEnglish (US)
Pages (from-to)846-851
Number of pages6
JournalEnvironmental Health Perspectives
Volume102
Issue number10
StatePublished - 1994
Externally publishedYes

Fingerprint

Human Mammary Glands
Milk Proteins
Genetically Modified Animals
Breast
protein
milk
Animals
Proteins
Genes
Bioengineering
Environmental Health
Domestic Animals
Physiology
Therapeutics
Transgenes
Research
Genetic Promoter Regions
Toxicology
Farms
bioengineering

Keywords

  • Chronic and hereditary diseases
  • Environmental and health research
  • Gene expression
  • Lactation
  • Mammary gland
  • Therapeutic proteins
  • Transgenics

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Transgenic approaches for modifying the mammary gland to produce therapeutic proteins. / Romagnolo, Donato; DiAugustine, R. P.

In: Environmental Health Perspectives, Vol. 102, No. 10, 1994, p. 846-851.

Research output: Contribution to journalArticle

@article{198d9551969a4de5810455f48578f6d3,
title = "Transgenic approaches for modifying the mammary gland to produce therapeutic proteins",
abstract = "Bioengineering of the mammary gland to produce proteins of therapeutic and industrial value is the result of extensive investigation of thy physiology of the mammary gland and the ability to generate transgenic animals. Targeting the expression of heterologous proteins to mammary tissue requires a thorough understanding of the biochemical events that coordinate growth and differentiation of the mammary gland and of the hormonal and developmental regulation of expression of milk protein genes. The characterization of mammary-specific promoter regions in milk protein genes and knowledge of the mechanisms that confer integration site-independent expression of transgenes have significantly contributed to modifying the mammary gland to produce heterologous proteins of therapeutic interest. The generation of large transgenic farm animals provides the opportunity for large-scale production of proteins in milk that have a therapeutic value are naturally present at low concentrations in biological fluids. Transgenic mammary epithelial cells offer a versatile research model in biomedical, environmental health, and neonatal toxicology research.",
keywords = "Chronic and hereditary diseases, Environmental and health research, Gene expression, Lactation, Mammary gland, Therapeutic proteins, Transgenics",
author = "Donato Romagnolo and DiAugustine, {R. P.}",
year = "1994",
language = "English (US)",
volume = "102",
pages = "846--851",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "10",

}

TY - JOUR

T1 - Transgenic approaches for modifying the mammary gland to produce therapeutic proteins

AU - Romagnolo, Donato

AU - DiAugustine, R. P.

PY - 1994

Y1 - 1994

N2 - Bioengineering of the mammary gland to produce proteins of therapeutic and industrial value is the result of extensive investigation of thy physiology of the mammary gland and the ability to generate transgenic animals. Targeting the expression of heterologous proteins to mammary tissue requires a thorough understanding of the biochemical events that coordinate growth and differentiation of the mammary gland and of the hormonal and developmental regulation of expression of milk protein genes. The characterization of mammary-specific promoter regions in milk protein genes and knowledge of the mechanisms that confer integration site-independent expression of transgenes have significantly contributed to modifying the mammary gland to produce heterologous proteins of therapeutic interest. The generation of large transgenic farm animals provides the opportunity for large-scale production of proteins in milk that have a therapeutic value are naturally present at low concentrations in biological fluids. Transgenic mammary epithelial cells offer a versatile research model in biomedical, environmental health, and neonatal toxicology research.

AB - Bioengineering of the mammary gland to produce proteins of therapeutic and industrial value is the result of extensive investigation of thy physiology of the mammary gland and the ability to generate transgenic animals. Targeting the expression of heterologous proteins to mammary tissue requires a thorough understanding of the biochemical events that coordinate growth and differentiation of the mammary gland and of the hormonal and developmental regulation of expression of milk protein genes. The characterization of mammary-specific promoter regions in milk protein genes and knowledge of the mechanisms that confer integration site-independent expression of transgenes have significantly contributed to modifying the mammary gland to produce heterologous proteins of therapeutic interest. The generation of large transgenic farm animals provides the opportunity for large-scale production of proteins in milk that have a therapeutic value are naturally present at low concentrations in biological fluids. Transgenic mammary epithelial cells offer a versatile research model in biomedical, environmental health, and neonatal toxicology research.

KW - Chronic and hereditary diseases

KW - Environmental and health research

KW - Gene expression

KW - Lactation

KW - Mammary gland

KW - Therapeutic proteins

KW - Transgenics

UR - http://www.scopus.com/inward/record.url?scp=0028007637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028007637&partnerID=8YFLogxK

M3 - Article

C2 - 9644191

AN - SCOPUS:0028007637

VL - 102

SP - 846

EP - 851

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 10

ER -